Holding(s) in Company

RNS Number : 2172T

Intl. Biotechnology Trust PLC

23 September 2010

 



TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

2. Reason for the notification (please place an X inside the appropriate bracket/s):

An acquisition or disposal of voting rights: ()

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ()

An event changing the breakdown of voting rights: ()

Other: Following the sale of part of the AXA Life Insurance business to Resolution PLC, changes have been made to the direct and indirect holdings: (X)

3. Full name of person(s) subject to the notification obligation (iii):

AXA S.A, 25 Avenue Matignon, 75008 Paris and its group of companies

4. Full name of shareholder(s) (if different from 3.) (iv):

5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v):

15 September 2010

6. Date on which issuer notified:

23 September 2010

7. Threshold(s) that is/are crossed or reached:

3%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares if possible using the ISIN CODE	Situation previous to the Triggering transaction (vi)
	Number of shares	Number of voting Rights (viii)
Ordinary Shares GB0004559349	3,161,050	3,161,050

Resulting situation after the triggering transaction (vii)

Class/type of shares if possible using the ISIN CODE	Number of shares	Number of voting rights (ix)		% of voting rights
		Direct (x)	Indirect (xi)	Direct	Indirect
Ordinary Shares GB0004559349	7,856	7,856	3,140,368	0.01	5.20

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction (xii)

Type of financial instrument	Expiration Date (xiii)	Exercise/Conversion Period/ Date (xiv)	Number of voting rights that may be acquired if the instrument is exercised/ converted.	% of voting rights
N/A	N/A	N/A	N/A	N/A

C: Financial Instruments with similar economic effect to Qualify Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument	Exercise price	Exercise/Conversion Period	Number of voting rights instrument refers to	% of voting rights
				Nominal	Delta
N/A	N/A	N/A	N/A	N/A	N/A

Total (A+B+C)

Number of voting rights	% of voting rights
3,148,224	5.22

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable ^(xv):

Name of the Company/Fund	Number of Shares	% of issued share capital
AXA IM UK Indirect	3,140,368.00	5.202932
Sun Life International (IOM) Ltd Direct	7,856.00	0.013016
Total Direct	7,856	0.1302
Total Indirect	3,140,368	5.20293
TOTAL	3,148,224	5.21595

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

N/A

14. Contact name:

Kyere Tabiri

15. Contact telephone number:

020 7003 1510

Date: 23 SEPTEMBER 2010

 

END

 

 

HOLUOASRRSAKUAR